CATALOGO DEI PRODOTTI DELLA RICERCA

Maggino, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.690
EU - Europa 3.477
AS - Asia 2.671
SA - Sud America 346
AF - Africa 89
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.286
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.604
RU - Federazione Russa 1.510
SG - Singapore 1.062
CN - Cina 791
GB - Regno Unito 515
IT - Italia 373
BR - Brasile 262
HK - Hong Kong 236
DE - Germania 233
VN - Vietnam 221
FR - Francia 207
IE - Irlanda 190
SE - Svezia 169
KR - Corea 83
FI - Finlandia 82
BD - Bangladesh 62
IN - India 49
CA - Canada 48
UA - Ucraina 48
JP - Giappone 44
AR - Argentina 34
NL - Olanda 34
MX - Messico 25
TR - Turchia 21
PL - Polonia 20
NG - Nigeria 19
ID - Indonesia 18
BE - Belgio 15
ES - Italia 15
IQ - Iraq 12
ZA - Sudafrica 12
DZ - Algeria 11
TG - Togo 11
EC - Ecuador 10
AT - Austria 9
SA - Arabia Saudita 9
AU - Australia 8
BJ - Benin 8
CL - Cile 8
UZ - Uzbekistan 8
CO - Colombia 7
CZ - Repubblica Ceca 7
MA - Marocco 7
PE - Perù 7
PY - Paraguay 7
AL - Albania 6
KE - Kenya 6
PH - Filippine 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
AZ - Azerbaigian 4
HU - Ungheria 4
JM - Giamaica 4
KG - Kirghizistan 4
MY - Malesia 4
NO - Norvegia 4
PK - Pakistan 4
PT - Portogallo 4
RO - Romania 4
TN - Tunisia 4
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
LT - Lituania 3
LV - Lettonia 3
UG - Uganda 3
DK - Danimarca 2
IR - Iran 2
KZ - Kazakistan 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
Totale 10.274
Salva come PNG Salva come JPEG
Città #
Singapore 536
Moscow 515
Ashburn 503
Southend 438
Chandler 418
San Jose 353
Dallas 338
Hong Kong 227
Dublin 186
Verona 182
Beijing 175
Jacksonville 153
The Dalles 143
Council Bluffs 126
Woodbridge 111
Ho Chi Minh City 79
Munich 73
Los Angeles 71
Lawrence 65
Princeton 65
New York 61
Houston 59
Jinan 55
Hanoi 52
Redmond 49
Wilmington 45
Nanjing 43
Helsinki 40
Shenyang 39
Santa Clara 35
São Paulo 35
Tokyo 35
Redondo Beach 34
Buffalo 31
Orem 30
Tianjin 29
Columbus 28
Ann Arbor 24
Haikou 24
Hangzhou 23
Redwood City 23
Frankfurt am Main 21
Milan 21
Changsha 19
Hebei 19
Montreal 19
Ningbo 19
Sindelfingen 19
London 18
Nanchang 18
Seattle 18
Turku 18
Abuja 17
Falkenstein 16
Toronto 16
Warsaw 16
Atlanta 15
Brooklyn 15
Brussels 15
Rio de Janeiro 15
Washington 15
Amsterdam 14
Chennai 14
Denver 14
Nuremberg 13
Zhengzhou 13
Fairfield 12
Chicago 11
Lomé 11
Mexico City 11
Norwalk 11
Taiyuan 11
Taizhou 11
Fuzhou 10
Haiphong 10
Paris 10
San Francisco 10
Belo Horizonte 9
Jakarta 9
Johannesburg 9
Lancaster 9
Lappeenranta 9
Mumbai 9
Stockholm 9
Cotonou 8
Falls Church 8
Genoa 8
Miami 8
Tashkent 8
Baghdad 7
Guangzhou 7
Istanbul 7
Manchester 7
Phoenix 7
Poplar 7
Ankara 6
Boston 6
Curitiba 6
Des Moines 6
Dongguan 6
Totale 6.261
Salva come PNG Salva come JPEG
Nome #
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 254
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 220
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 217
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 215
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 190
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 185
Results of a surveillance protocol for pancreatic BD-IPMNs 185
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 183
An unforeseeable adverse event during ERCP 182
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 179
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 178
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 175
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 175
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 173
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 170
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 160
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC) An International Delphi Study Among Patients and Health Care Providers 159
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group 158
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 158
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? 157
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 154
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 152
Assessment of a complication risk score and study of complication profile in laparoscopic distal pancreatectomy 151
Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer 151
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 151
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma 150
Assessing the influence of experience in pancreatic surgery: a risk-adjusted analysis using the American College of Surgeons NSQIP database 146
Pancreatic Adenocarcinoma 145
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer 144
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 144
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 139
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 138
Defining the practice of distal pancreatectomy around the world 138
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 136
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 135
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer 135
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia 133
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 132
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) 131
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation 129
Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer 129
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis 126
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 126
Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? 125
Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol 122
ASO Author Reflection: Location of Nodal Metastases in Pancreatoduodenectomy for Cancer: Which Station Matters? 120
Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey 117
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis 115
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies 110
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 109
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 107
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review 107
The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy 102
Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma 100
Extended Experience with a Dynamic, Data-Driven Selective Drain Management Protocol in Pancreaticoduodenectomy: Progressive Risk Stratification for Better Practice 99
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 98
Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy 97
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 95
Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis 94
Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis 91
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 91
Surgical experience and the practice of pancreatoduodenectomy 90
Response to: Managing the High-risk Pancreatic Anastomosis 88
Intraductal Papillary Mucinous Neoplasm Around the World 88
The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy 87
Trends in practice patterns and outcomes: A decade of sarcoma care in the United States 87
The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy 85
Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database 81
Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes 80
Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution? 80
Response to Comment on "Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma" 78
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 78
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review 73
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 72
Response to: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation" 71
Forecasting surgical costs: Towards informed financial consent and financial risk reduction 70
Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm? 67
Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score 65
Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study 62
Totale 10.421
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.183
article - articoli 36.951
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 777
patent - brevetti 0
selected - selezionate 0
volume - volumi 455
Totale 76.366
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022459 45 120 10 24 10 10 12 33 29 16 32 118
2022/20231.168 71 139 102 195 100 300 30 79 106 11 22 13
2023/2024639 26 64 64 65 67 115 54 42 14 18 79 31
2024/20251.623 81 90 54 251 79 34 98 114 229 118 146 329
2025/20264.986 365 218 343 742 1.304 321 447 278 386 307 87 188
Totale 10.421